Price
$39.44
Decreased by -3.59%
Dollar volume (20D)
3.64 M
ADR%
3.00
Earnings report date
Feb 4, 2025
Shares float
9.96 M
Shares short
516.56 K [5.19%]
Shares outstanding
19.06 M
Market cap
779.73 M
Beta
0.89
Price/earnings
14.30
20D range
34.15 41.84
50D range
34.15 41.84
200D range
34.15 52.75

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe.

The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.

It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups.

In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products.

It offers its products through retail stores and online.

The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau.

USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Oct 22, 24 0.56
Decreased by -5.08%
0.49
Increased by +14.29%
Jul 23, 24 0.54
Decreased by -39.33%
0.65
Decreased by -16.92%
Apr 30, 24 0.86
Decreased by -9.47%
0.69
Increased by +24.64%
Feb 6, 24 0.87
Increased by +31.82%
0.52
Increased by +67.31%
Oct 24, 23 0.59
Decreased by -24.36%
0.64
Decreased by -7.81%
Jul 25, 23 0.89
Decreased by -11.00%
0.70
Increased by +27.14%
Apr 25, 23 0.95
Decreased by -17.39%
0.77
Increased by +23.38%
Feb 7, 23 0.66
Decreased by -35.92%
0.35
Increased by +88.57%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 24 200.22 M
Decreased by -6.16%
10.61 M
Decreased by -6.52%
Increased by +5.30%
Decreased by -0.38%
Jun 30, 24 212.87 M
Decreased by -10.64%
10.43 M
Decreased by -39.67%
Increased by +4.90%
Decreased by -32.49%
Mar 31, 24 227.80 M
Decreased by -8.28%
16.54 M
Decreased by -10.04%
Increased by +7.26%
Decreased by -1.92%
Dec 31, 23 221.08 M
Decreased by -3.02%
16.77 M
Increased by +31.04%
Increased by +7.58%
Increased by +35.11%
Sep 30, 23 213.37 M
Decreased by -8.54%
11.35 M
Decreased by -23.99%
Increased by +5.32%
Decreased by -16.89%
Jun 30, 23 238.20 M
Decreased by -9.93%
17.29 M
Decreased by -9.74%
Increased by +7.26%
Increased by +0.22%
Mar 31, 23 248.36 M
Decreased by -8.98%
18.38 M
Decreased by -18.19%
Increased by +7.40%
Decreased by -10.11%
Dec 31, 22 227.96 M
Decreased by -14.72%
12.79 M
Decreased by -37.03%
Increased by +5.61%
Decreased by -26.17%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY